Scientists of CIBER-BBN and NANBIOSIS ICTS have participated in the 4th Conference “Anticipating the Medicine of the Future”, which took place on November 30th, organized by the Roche Institute Foundation. The topics for this ediction had been identified by the Observatory of Trends in the Medicine of the Future: Pharmacogenomics, Nanomedicine and Epigenomic
The event counted with three roundtables for discussion in relation to the three topics. The second one, on Nanomedicine, was moderated by Joaquín Arenas, Director of the Research Institute of the 12 de Octubre University Hospital.
Ramón Martínez Máñez, Professor of Inorganic Chemistry at the Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM) of the Polytechnic University of Valencia and Scientific Director of CIBER-BBN and Unit 26 of NANBIOSIS gave a talk entitled “Macro problems, nano solutions”. After that, the debate was openwith the participation of Maria Pilar Marco, Research Professor of the Spanish Council for Scientific Research (CSIC) and Coordinator of the Nanomedicine Research Program CIBER-BBN and Scientific Director of unit 2 of NANBIOSIS, CAbS, José Becerra, Emeritus Professor of of Cell Biology of the University of Malaga and Principal Investigator of CIBER-BBN, BIONAND and IBIMA and Maria Jesús Vicent, Coordinator of the Advanced Therapies Area of the Principe Felipe Research Center.
The Roundtable discussed the applications of nanomedicine in the Medicine of the Future and in Personalized Precision Medicine, as well as the challenges facing nanomedicine.
The Observatory of Trends in the Medicine of the Future, promoted by the Roche Institute Foundation, aims to generate and disseminate knowledge in areas of incipient knowledge related to Personalized Precision Medicine and that are part of the Medicine of the Future.
In this context, the fundation Instituto Roche has recently published a report on nanomedicine coordinated by Ramón Martínez in which José Becerra, María Pilar Marco and María Jesús Vicent have participated as experts.
Currently, nanoparticles or nanostructures are being applied for the controlled release of drugs in cancer and other pathologies and nanodevices for the diagnosis of diseases or the development of nanomaterials for applications in regenerative medicine. In the coming years, and with the translation into clinical practice of more and more developments based on these technologies, nanomedicine will contribute to the medicine of the future approaching the diagnosis and treatment of diseases earlier, more efficiently and in a more efficient and personalized way.
